According to a recent LinkedIn post from Glooko, the company is positioning its diabetes data management platform as the first outside Roche’s ecosystem to integrate with the Accu-Chek SmartGuide continuous glucose monitor. The integration is described as being available in select European markets and is presented as a way to consolidate data that currently sits in separate device-specific apps and portals.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post highlights comments from CEO Mike Alvarez, who discusses how unifying data streams could improve visibility for both patients and clinicians in diabetes care. For investors, this suggests Glooko is pursuing interoperability with major device manufacturers, which could enhance its value proposition, support user growth in Europe, and potentially strengthen its competitive standing in the digital diabetes management segment.